DFN-02
Phase 3Completed 2 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Migraine
Conditions
Acute Migraine
Trial Timeline
Sep 1, 2014 → Mar 1, 2016
NCT ID
NCT02279082About DFN-02
DFN-02 is a phase 3 stage product being developed by Dr. Reddy's Laboratories for Acute Migraine. The current trial status is completed. This product is registered under clinical trial identifier NCT02279082. Target conditions include Acute Migraine.
What happened to similar drugs?
20 of 20 similar drugs in Acute Migraine were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02279082 | Phase 3 | Completed |
Competing Products
20 competing products in Acute Migraine